Abbott Diabetes Care
Clinical trials sponsored by Abbott Diabetes Care, explained in plain language.
Now part of
Abbott Laboratories
ABT
NYSE
Develops glucose monitoring devices for diabetes.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Glucose monitor study aims to uncover hidden signs of prediabetes Results expected Dec 2026 (estimated)
- New glucose monitor aims to prevent dangerous low blood sugar in kids Results expected Dec 2026 (estimated)